[{"id":"6c019962-d884-4450-8e74-47d46113f864","acronym":"","url":"https://clinicaltrials.gov/study/NCT03937154","created_at":"2021-01-18T19:23:23.104Z","updated_at":"2025-02-25T13:52:53.665Z","phase":"Phase 3","brief_title":"Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer","source_id_and_acronym":"NCT03937154","lead_sponsor":"Amgen","biomarkers":" HER-2","pipe":"","alterations":" ","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Nplate (romiplostim)"],"overall_status":"Recruiting","enrollment":" Enrollment 162","initiation":"Initiation: 02/26/2020","start_date":" 02/26/2020","primary_txt":" Primary completion: 05/20/2026","primary_completion_date":" 05/20/2026","study_txt":" Completion: 05/20/2027","study_completion_date":" 05/20/2027","last_update_posted":"2025-02-20"},{"id":"b897659f-c291-4374-a95c-325d7d050fce","acronym":"","url":"https://clinicaltrials.gov/study/NCT03362177","created_at":"2021-01-18T16:35:45.317Z","updated_at":"2024-07-02T16:35:21.066Z","phase":"Phase 3","brief_title":"Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer","source_id_and_acronym":"NCT03362177","lead_sponsor":"Amgen","biomarkers":" EGFR","pipe":"","alterations":" ","tags":["EGFR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e oxaliplatin • Nplate (romiplostim)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 162","initiation":"Initiation: 09/30/2019","start_date":" 09/30/2019","primary_txt":" Primary completion: 01/25/2024","primary_completion_date":" 01/25/2024","study_txt":" Completion: 01/24/2025","study_completion_date":" 01/24/2025","last_update_posted":"2024-02-02"},{"id":"2325ad67-a6c7-40b4-b0a4-40263229ded9","acronym":"RIGOLETTO","url":"https://clinicaltrials.gov/study/NCT04933942","created_at":"2021-06-22T15:52:35.716Z","updated_at":"2024-07-02T16:35:47.227Z","phase":"Phase 2","brief_title":"Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma","source_id_and_acronym":"NCT04933942 - RIGOLETTO","lead_sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","biomarkers":" IDH1 • MGMT","pipe":" | ","alterations":" MGMT promoter methylation • IDH1 R132H • IDH1 R132","tags":["IDH1 • MGMT"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MGMT promoter methylation • IDH1 R132H • IDH1 R132"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e lomustine • Nplate (romiplostim)"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 09/13/2022","start_date":" 09/13/2022","primary_txt":" Primary completion: 12/19/2022","primary_completion_date":" 12/19/2022","study_txt":" Completion: 12/19/2022","study_completion_date":" 12/19/2022","last_update_posted":"2023-05-24"}]